Pancreatic Cancer

>

Latest News

TTFields/Chemotherapy Improves Survival in Advanced Pancreatic Cancer
TTFields/Chemotherapy Improves Survival in Advanced Pancreatic Cancer

December 3rd 2024

Tumor treating fields with chemotherapy improved overall survival for patients with unresectable, locally advanced pancreatic adenocarcinoma.

Shubham Pant, MD, MBBS, highlights how pan-RAS inhibitors, RAS-directed vaccines, and biomarker testing can improve outcomes in pancreatic cancer.
Biomarker Testing, Targeted Agents May Impact RAS+ Pancreatic Cancer Care

November 30th 2024

The incorporation of palliative care specific to mental health services and therapy remains underutilized in the care of patients with pancreatic cancer.
Palliative Care May Improve Mental Health in Pancreatic Cancer Diagnoses

November 19th 2024

Managing Pancreatic Cancer Through Risk Factors, Diagnosis, and AEs
Managing Pancreatic Cancer Through Risk Factors, Diagnosis, and AEs

November 18th 2024

The 18-month overall survival rate with the mitazalimab combination in OPTIMIZE-1 exceeds a historical rate achieved with FOLFIRINOX alone.
Mitazalimab Combo Yields Meaningful Survival Benefit in Metastatic PDAC

November 7th 2024